{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:44:47Z","timestamp":1759452287642,"version":"build-2065373602"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,2]]},"DOI":"10.7759\/cureus.93715","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T14:53:01Z","timestamp":1759416781000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Adipophilin-Positive Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN) With Eosinophilia"],"prefix":"10.7759","author":[{"given":"Takahiro","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"Tanaka M","year":"2017","unstructured":"Tanaka M, Fern\u00e1ndez-Del Castillo C, Kamisawa T, et al.. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017, 17:738-53. 10.1016\/j.pan.2017.07.007","journal-title":"Pancreatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2012.04.004","article-title":"International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas","volume":"12","author":"Tanaka M","year":"2012","unstructured":"Tanaka M, Fern\u00e1ndez-del Castillo C, Adsay V, et al.. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012, 12:183-97. 10.1016\/j.pan.2012.04.004","journal-title":"Pancreatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2478\/rjim-2018-0041","article-title":"Causes of eosinophilic ascites - a systematic review","volume":"57","author":"Pinte L","year":"2019","unstructured":"Pinte L, Baicu\u015f C. Causes of eosinophilic ascites - a systematic review. Rom J Intern Med. 2019, 57:110-24. 10.2478\/rjim-2018-0041","journal-title":"Rom J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2024.100928","article-title":"Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: an innovative multidisciplinary approach","volume":"17","author":"Caminati M","year":"2024","unstructured":"Caminati M, Carpagnano LF, Alberti C, et al.. Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: an innovative multidisciplinary approach. World Allergy Organ J. 2024, 17:100928. 10.1016\/j.waojou.2024.100928","journal-title":"World Allergy Organ J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00853-0","article-title":"Eosinophils in the pathogenesis of pancreatic disorders","volume":"43","author":"Manohar M","year":"2021","unstructured":"Manohar M, Kandikattu HK, Upparahalli Venkateshaiah S, Yadavalli CS, Mishra A. Eosinophils in the pathogenesis of pancreatic disorders. Semin Immunopathol. 2021, 43:411-22. 10.1007\/s00281-021-00853-0","journal-title":"Semin Immunopathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.033381","article-title":"Immunohistochemical staining for adipophilin, perilipin and TIP47","volume":"59","author":"Muthusamy K","year":"2006","unstructured":"Muthusamy K, Halbert G, Roberts F. Immunohistochemical staining for adipophilin, perilipin and TIP47. J Clin Pathol. 2006, 59:1166-70. 10.1136\/jcp.2005.033381","journal-title":"J Clin Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00646.2009","article-title":"Adipose differentiation-related protein regulates lipids and insulin in pancreatic islets","volume":"299","author":"Faleck DM","year":"2010","unstructured":"Faleck DM, Ali K, Roat R, et al.. Adipose differentiation-related protein regulates lipids and insulin in pancreatic islets. Am J Physiol Endocrinol Metab. 2010, 299:E249-57. 10.1152\/ajpendo.00646.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-210198","article-title":"Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms","volume":"33","author":"Honda K","year":"2022","unstructured":"Honda K. Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms. Cancer Biomark. 2022, 33:503-12. 10.3233\/CBM-210198","journal-title":"Cancer Biomark"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0122-3","article-title":"Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism","volume":"20","author":"Patra KC","year":"2018","unstructured":"Patra KC, Kato Y, Mizukami Y, et al.. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism. Nat Cell Biol. 2018, 20:811-22. 10.1038\/s41556-018-0122-3","journal-title":"Nat Cell Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46634-6","article-title":"Integrated targeted metabolomic and lipidomic analysis: a novel approach to classifying early cystic precursors to invasive pancreatic cancer","volume":"9","author":"Gaiser RA","year":"2019","unstructured":"Gaiser RA, Pessia A, Ateeb Z, et al.. Integrated targeted metabolomic and lipidomic analysis: a novel approach to classifying early cystic precursors to invasive pancreatic cancer. Sci Rep. 2019, 9:10208. 10.1038\/s41598-019-46634-6","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12955","article-title":"How I investigate eosinophilia","volume":"41","author":"Larsen RL","year":"2019","unstructured":"Larsen RL, Savage NM. How I investigate eosinophilia. Int J Lab Hematol. 2019, 41:153-61. 10.1111\/ijlh.12955","journal-title":"Int J Lab Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.6.4-6.487","article-title":"The toxic effects of formaldehyde and formalin","volume":"6","author":"Fischer MH","year":"1905","unstructured":"Fischer MH. The toxic effects of formaldehyde and formalin. J Exp Med. 1905, 6:487-518. 10.1084\/jem.6.4-6.487","journal-title":"J Exp Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.04.025","article-title":"Eosinophils in health and disease: a state-of-the-art review","volume":"96","author":"Wechsler ME","year":"2021","unstructured":"Wechsler ME, Munitz A, Ackerman SJ, et al.. Eosinophils in health and disease: a state-of-the-art review. Mayo Clin Proc. 2021, 96:2694-707. 10.1016\/j.mayocp.2021.04.025","journal-title":"Mayo Clin Proc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00027","article-title":"Eosinophil recruitment and activation: the role of lipid mediators","volume":"4","author":"Luna-Gomes T","year":"2013","unstructured":"Luna-Gomes T, Bozza PT, Bandeira-Melo C. Eosinophil recruitment and activation: the role of lipid mediators. Front Pharmacol. 2013, 4:27. 10.3389\/fphar.2013.00027","journal-title":"Front Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1590\/s0074-02761997000800026","article-title":"A role for lymphocytes and cytokines on the eosinophil migration induced by LPS","volume":"92 Suppl 2","author":"Castro-Faria-Neto HC","year":"1997","unstructured":"Castro-Faria-Neto HC, Penido CM, Larangeira AP, Silva AR, Bozza PT. A role for lymphocytes and cytokines on the eosinophil migration induced by LPS. Mem Inst Oswaldo Cruz. 1997, 92 Suppl 2:197-200. 10.1590\/s0074-02761997000800026","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2017.07.521","article-title":"Prostaglandin E2: a pancreatic fluid biomarker of intraductal papillary mucinous neoplasm dysplasia","volume":"225","author":"Yip-Schneider MT","year":"2017","unstructured":"Yip-Schneider MT, Carr RA, Wu H, Schmidt MC. Prostaglandin E2: a pancreatic fluid biomarker of intraductal papillary mucinous neoplasm dysplasia. J Am Coll Surg. 2017, 225:481-7. 10.1016\/j.jamcollsurg.2017.07.521","journal-title":"J Am Coll Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000001377","article-title":"Pancreatic fluid interleukin-1\u03b2 complements prostaglandin e2 and serum carbohydrate antigen 19-9 in prediction of intraductal papillary mucinous neoplasm dysplasia","volume":"48","author":"Simpson RE","year":"2019","unstructured":"Simpson RE, Yip-Schneider MT, Flick KF, Wu H, Colgate CL, Schmidt CM. Pancreatic fluid interleukin-1\u03b2 complements prostaglandin e2 and serum carbohydrate antigen 19-9 in prediction of intraductal papillary mucinous neoplasm dysplasia. Pancreas. 2019, 48:1026-31. 10.1097\/MPA.0000000000001377","journal-title":"Pancreas"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00594-x","article-title":"Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells","volume":"18","author":"Gitto SB","year":"2020","unstructured":"Gitto SB, Beardsley JM, Nakkina SP, et al.. Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells. Cell Commun Signal. 2020, 18:95. 10.1186\/s12964-020-00594-x","journal-title":"Cell Commun Signal"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00703-y","article-title":"Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progression","volume":"5","author":"Bhattacharyya S","year":"2024","unstructured":"Bhattacharyya S, Oon C, Diaz L, et al.. Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progression. Nat Cancer. 2024, 5:283-98. 10.1038\/s43018-023-00703-y","journal-title":"Nat Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-020-02777-w","article-title":"The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma","volume":"477","author":"Hirai H","year":"2020","unstructured":"Hirai H, Tada Y, Nakaguro M, et al.. The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma. Virchows Arch. 2020, 477:291-9. 10.1007\/s00428-020-02777-w","journal-title":"Virchows Arch"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/390492-a-case-of-adipophilin-positive-pancreatic-intraductal-papillary-mucinous-neoplasm-ipmn-with-eosinophilia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T14:53:01Z","timestamp":1759416781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/390492-a-case-of-adipophilin-positive-pancreatic-intraductal-papillary-mucinous-neoplasm-ipmn-with-eosinophilia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.93715","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,2]]}}}